SmithKline Beecham buys US companyBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6955.629 (Published 10 September 1994) Cite this as: BMJ 1994;309:629
- C Court
SmithKline Beecham, a British pharmaceutical group, has announced that it is to buy the American company Sterling Health for $2.9bn (pounds sterling1.8bn). The move will make it the world's largest consumer drugs business. Sterling Health is the non-prescription business of Sterling Winthrop.
Since Smith Kline and French's merger with Beecham in July 1989 the company has always said that its aim is to become the world's leading health care company, not just in pharmaceuticals but in over the counter and other areas too, such as animal health and clinical laboratory testing. Analysts believe that such diversification is becoming increasingly necessary for drug companies …